Reduced MACE and Limb Events in Patients With Diabetes Treated With GLP1RAs vs DPP4is
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Major Adverse Cardiovascular and Limb Events in Patients With Diabetes Treated With GLP-1 Receptor Agonists vs DPP-4 Inhibitors
Diabetologia 2021 Sep 01;64(9)1949-1962, DS Lin, JK Lee, WJ ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.